Evidence map›Paper›PMID 41339905›Full record

ArticleJournal of ovarian research2025

Deciphering the molecular landscape of NMDAR-E associated ovarian teratomas: a Multi-Omics approach.

Lingwei Ma, Xinmeng Sun, Shaohua Zhang, Yinping Xiao, Haiyun Guan, Rongmin Wang, Zhijing Tang, Wei Zhang, Hexia Xia

Abstract read
In one paragraph

Article in Journal of ovarian research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lingwei Ma *Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University and Shanghai Key Laboratory of Female Reproductive Endocrine Related Disease, Shanghai, 200011, China.
Xinmeng Sun *Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University and Shanghai Key Laboratory of Female Reproductive Endocrine Related Disease, Shanghai, 200011, China.
Shaohua Zhang *Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University and Shanghai Key Laboratory of Female Reproductive Endocrine Related Disease, Shanghai, 200011, China.
Yinping XiaoDepartment of Pathology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, China.
Haiyun GuanDepartment of Gynecology, Obstetrics and Gynecology Hospital of Fudan University and Shanghai Key Laboratory of Female Reproductive Endocrine Related Disease, Shanghai, 200011, China.
Rongmin WangDepartment of Gynecology, Obstetrics and Gynecology Hospital of Fudan University and Shanghai Key Laboratory of Female Reproductive Endocrine Related Disease, Shanghai, 200011, China.
Zhijing TangDepartment of Reproductive Endocrinology, Obstetrics and Gynecology Hospital of Fudan University and Shanghai Key Laboratory of Female Reproductive Endocrine Related Disease, Shanghai, 200011, China.
Wei ZhangDepartment of Reproductive Endocrinology, Obstetrics and Gynecology Hospital of Fudan University and Shanghai Key Laboratory of Female Reproductive Endocrine Related Disease, Shanghai, 200011, China. zhangwei623@hotmail.com.
Hexia XiaDepartment of Gynecology, Obstetrics and Gynecology Hospital of Fudan University and Shanghai Key Laboratory of Female Reproductive Endocrine Related Disease, Shanghai, 200011, China. xhx0101@hotmail.com.

Funding

Shanghai Pujiang Program 21PJD006
6 · The paper itself

Abstract

backgroundAnti-N-methyl-D-aspartate receptor encephalitis (NMDAR-E) is an autoimmune disorder often associated with ovarian teratomas. It involves antibodies against the neuronal NMDAr1 subunits of NR1, but the pathogenesis and molecular mechanisms are not fully understood. To identify significantly differentially expressed genes and proteins and investigate the intricate molecular regulatory network underlying anti-NMDA receptor encephalitis (NMDAR-E) associated with ovarian teratomas.

methodsThis retrospective study analyzed ovarian teratoma samples from patients with and without NMDAR-E. RNA sequencing and iTRAQ coupled LC-MS/MS analysis were used for gene and protein expression profiling. qPCR and western blotting were used to validate the gene and protein expression.

resultsWe identified 2524 significantly differentially expressed genes and 34 proteins. The changes were notable at the mRNA and protein levels in ovarian teratomas associated with NMDAR-E. Functional enrichment analysis highlighted the extracellular matrix and immune activation pathways. Key genes and proteins involved in ferroptosis and immune activation, including SLC40A1, GGH, FKBP11, CCDC80, and ANK3, showed significant expression differences.

conclusionsOur findings provide preliminary insights into the pathophysiology of NMDAR-E associated with ovarian teratomas. These results may generate hypotheses for future mechanistic studies, and the candidate biomarkers identified warrant further validation before clinical translation.

Indexed as

Anti-N-Methyl-D-Aspartate Receptor EncephalitisOvarian NeoplasmsTeratomaFemaleGene Expression ProfilingHumansMultiomicsProteomicsReceptors, N-Methyl-D-AspartateRetrospective StudiesReceptors, N-Methyl-D-AspartateAnti-N-methyl-D-aspartate receptor encephalitisFerroptosisOvarian teratomaProteomicsTranscriptomics

Identifiers

PMID41339905
PMCPMC12676869

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.